ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors.

Robin L Jones et al.PubMed ↗Publisher ↗

No numbers read from the abstract.